Coronary Artery Disease, Left Main Coronary Artery Disease
Conditions
Brief summary
This hospital-based registry study at Istanbul Medipol University Hospital focuses on documenting and analyzing the clinical and demographic characteristics, procedural-related aspects, and both short and long-term outcomes of patients undergoing left main coronary artery percutaneous coronary intervention (PCI). The study aims to identify predictors for adverse clinical outcomes in patients treated for left main coronary artery disease.
Interventions
DEVICEPercutaneous coronary intervention
balloon angioplasty, stent implantation, atherectomy, intravascular ultrasound.
Sponsors
Medipol University
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Inclusion criteria
* All patients undergoing any PCI procedure(s) in given timeframe will be included in this registry
Exclusion criteria
* Patients with no informed consent
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Incidence of Major Adverse Cardiac Events (MACE) within One Year Following Left Main Coronary Artery PCI | up to 1 month, 3 months, 1 year | The primary outcome measure will be the incidence of major adverse cardiac events (MACE) within one year post-procedure in patients undergoing left main coronary artery PCI. MACE is defined as a composite of clinically significant endpoints including all-cause mortality, non-fatal myocardial infarction, non-fatal stroke, and any revascularization procedures required after the initial PCI. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Ischemia-Driven Target Vessel Revascularization (ID-TVR) Ischemia-Driven Target Vessel Revascularization (ID-TVR) | 1 year | Revascularization procedure that is performed on a previously treated vessel in patients who have developed ischemia. |
| Procedure-Related Complications Within 30 Days of PCI | 1 month | This outcome will document the incidence of procedure-related complications, including bleeding, vascular complications, or acute kidney injury, occurring within 30 days post-PCI. |
| Health-Related Quality of Life (HRQoL) Scores One Year After PCI | 1 year | Health-related quality of life using standardized questionnaire (SF-36) one year after the PCI procedure |
| Rate of stent thrombosis | 1 month, 3 months, 1 year | Probable or definite stent thrombosis |
Countries
Turkey (Türkiye)
Outcome results
None listed